PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database
Understanding Breastfeeding Drug Safety Before getting into how GLP-1 medications behave in breast milk, it helps to understand why these questions are coming up more often
When dizziness comes with those features, it moves from a tolerable side effect to a potential emergency that needs urgent evaluation
Orforglipron is on a similar timeline to retatrutide, with potential approval in 2027 or 2028
95% CI, 0.77-0.84), though the SGLT2 inhibitor group had higher rates of diabetic ketoacidosis, genital infections and lower limb amputations
While the legal landscape for research peptides is genuinely complex, researchers should be wary of vendors who seem more focused on explaining why they can still sell tirzepatide than on demonstrating the quality of what they sell